Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.82	4.11	4.28	4.51	7.82	8.32
Cash & Short-Term Investments	6.82	4.11	4.28	4.51	7.82	8.32
Cash Growth	49.20%	-4.09%	-4.99%	-42.36%	-5.96%	-0.22%
Accounts Receivable	12.11	14.87	16.1	16.71	21.83	17.77
Receivables	12.11	14.87	16.1	16.71	21.83	17.77
Inventory	21.6	23.25	24.72	26.44	27.59	22.26
Other Current Assets	3.28	2.9	3.94	3.47	4.34	3.36
Total Current Assets	43.81	45.12	49.04	51.12	61.58	51.7
Property, Plant & Equipment	12.49	11.24	8.75	9.18	10.31	11.72
Long-Term Investments	-	-	3.5	-	-	-
Goodwill	9.53	56.32	57.07	56.26	57.69	58.59
Other Intangible Assets	8.38	11.13	16.04	21.01	27.39	33.15
Long-Term Deferred Tax Assets	-	0.09	0.44	0.33	0.21	0.26
Other Long-Term Assets	3.79	2.74	2.54	7.45	5.17	0.84
Total Assets	77.99	126.64	137.37	145.36	162.34	156.25
Accounts Payable	5.18	4.79	5.55	6.45	4.91	5.97
Accrued Expenses	2.34	2.26	4.43	3.87	6.53	4.15
Current Portion of Long-Term Debt	33.97	36.96	5.86	3.81	3.24	1.72
Current Portion of Leases	1.49	1.16	1.42	2.14	2.14	2.11
Current Income Taxes Payable	-	-	-	-	0.22	0.29
Current Unearned Revenue	2.88	3.81	4.51	3.37	4.27	3.77
Other Current Liabilities	8.55	5.99	4.78	3.62	4.01	3.05
Total Current Liabilities	54.4	54.96	26.54	23.25	25.32	21.05
Long-Term Debt	-	-	30.9	43.01	45.1	46.29
Long-Term Leases	7.33	6.38	4.79	5.28	6.49	7.48
Pension & Post-Retirement Benefits	-	-	-	-	-	1.59
Long-Term Deferred Tax Liabilities	0.73	0.71	0.78	0.59	1.56	1.9
Other Long-Term Liabilities	1.46	1.26	1.28	1.01	0.49	1.26
Total Liabilities	63.92	63.3	64.29	73.14	78.94	79.57
Common Stock	0.45	0.44	0.43	0.45	0.45	0.44
Additional Paid-In Capital	237.92	236.58	232.44	229.01	225.65	232.36
Retained Earnings	-211.86	-158.01	-145.61	-142.19	-132.67	-132.39
Treasury Stock	-	-	-	-	-	-10.67
Comprehensive Income & Other	-12.44	-15.67	-14.19	-15.05	-10.03	-13.07
Shareholders' Equity	14.07	63.34	73.07	72.22	83.4	76.68
Total Liabilities & Equity	77.99	126.64	137.37	145.36	162.34	156.25
Total Debt	42.79	44.5	42.97	54.24	56.96	57.6
Net Cash (Debt)	-35.97	-40.39	-35.19	-49.73	-49.14	-49.28
Net Cash Per Share	-0.81	-0.93	-0.83	-1.20	-1.22	-1.28
Filing Date Shares Outstanding	44.58	44.07	43.4	42.19	41.23	39.83
Total Common Shares Outstanding	44.58	44.07	43.39	42.08	41.14	39.41
Working Capital	-10.59	-9.84	22.5	27.88	36.27	30.65
Book Value Per Share	0.32	1.44	1.68	1.72	2.03	1.95
Tangible Book Value	-3.84	-4.12	-0.03	-5.05	-1.67	-15.06
Tangible Book Value Per Share	-0.09	-0.09	-0.00	-0.12	-0.04	-0.38
Machinery	-	18.36	15.95	15.71	15.3	18.02
Leasehold Improvements	-	2.57	2.42	2.51	2.56	2.54

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q